WHO Pain Ladder & Multimodal Analgesia

A client rates pain at 7/10 after surgery. Do you start with acetaminophen, tramadol, or morphine? The WHO ladder gives you the framework — but multimodal analgesia is why you often use all three.

The WHO analgesic ladder is a three-step framework originally designed for cancer pain but widely applied to guide pharmacological escalation. Step 1 (mild pain, 1-3): non-opioid analgesics such as acetaminophen or NSAIDs. Step 2 (moderate pain, 4-6): weak opioids like tramadol or codeine, often combined with Step 1 agents. Step 3 (severe pain, 7-10): strong opioids such as morphine, hydromorphone, or fentanyl, again combined with non-opioids. Adjuvant medications — anticonvulsants (gabapentin), antidepressants (duloxetine), or local anesthetics — can be added at any step. Multimodal analgesia means combining drugs from different classes that target different pain pathways simultaneously. The clinical advantage: lower doses of each individual drug, fewer opioid-related side effects (respiratory depression, constipation, sedation), and better overall pain control. Postoperative protocols now routinely pair scheduled acetaminophen and NSAIDs with PRN opioids rather than relying on opioids alone. The nurse's role is matching analgesic potency to current pain severity, reassessing after intervention, and escalating appropriately — not jumping straight to Step 3 for every pain complaint, but also not withholding strong opioids when the severity warrants them.

Key Distinctions

Don't confuse the WHO ladder (a pharmacological escalation framework) with non-pharmacological interventions — those are separate and complementary, not a ladder step. The ladder matches analgesic strength to current pain severity; it does not require sequential trial of every step starting from Step 1. Students often think multimodal means giving multiple opioids together; it actually means combining different drug classes. Adjuvant analgesics are not the same as PRN rescue doses — adjuvants target specific pain mechanisms like neuropathy, not breakthrough intensity.

Clinical Pearl

Think of the ladder as 'match the step to the severity, then combine smart.' Multimodal analgesia isn't polypharmacy — it's strategic layering that lets you use less opioid for more relief.